Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
3.020
+0.020 (0.67%)
At close: Mar 6, 2026, 4:00 PM EST
3.060
+0.040 (1.32%)
After-hours: Mar 6, 2026, 6:43 PM EST
Neumora Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 513 | 1,713 | 2,604 | - | - | - | |
| Market Cap Growth | 85.77% | -34.22% | - | - | - | - | |
| Enterprise Value | 362 | 1,374 | 2,090 | - | - | - | |
| Last Close Price | 3.02 | 10.60 | 17.05 | - | - | - | |
| PB Ratio | 3.70 | 5.97 | 5.55 | - | - | - | |
| P/TBV Ratio | 3.88 | 5.97 | 5.55 | - | - | - | |
| Debt / Equity Ratio | 0.15 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.15 | -1.06 | -0.98 | -0.97 | -1.01 | -1.01 | |
| Net Debt / EBITDA Ratio | 0.63 | 1.16 | 2.45 | 3.17 | 5.10 | 7.42 | |
| Net Debt / FCF Ratio | 0.73 | 1.67 | 2.81 | 3.35 | 5.34 | 6.77 | |
| Quick Ratio | 6.64 | 10.29 | 18.08 | 15.73 | 17.59 | 20.50 | |
| Current Ratio | 6.85 | 10.51 | 19.05 | 16.37 | 17.85 | 20.69 | |
| Return on Equity (ROE) | -104.35% | -64.48% | -54.49% | -32.67% | -80.18% | -106.02% | |
| Return on Assets (ROA) | -56.71% | -40.50% | -25.50% | -17.95% | -16.01% | - | |
| Return on Capital Employed (ROCE) | -158.30% | -91.80% | -39.90% | -30.50% | -19.80% | -13.60% | |
| Earnings Yield | -46.04% | -14.24% | -9.06% | - | - | - | |
| FCF Yield | -40.54% | -10.68% | -6.28% | - | - | - | |
| Buyback Yield / Dilution | -2.49% | -145.12% | -138.99% | -24.25% | -68.46% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.